A129S (p.Ala129Ser) variant of AGT (Angiotensinogen)

A129S (p.Ala129Ser) in AGT (Angiotensinogen) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.29 / 1. The record also includes population frequency data and structural context.

A129S (p.Ala129Ser) variant details